Ryan Fitzpatrick really has this "Movember" thing all mixed up. With men everywhere using "No-Shave November" as an excuse to not shave to bring awareness to prostate cancer, Fitzpatrick has gone the other way. With the New York Jets...Show More Summary
Cases of prostate cancer are down, but likely because with less PSA testing, fewer are detected.
A new drug combination may be effective in treating men with metastatic prostate cancer. Preliminary results of this new approach are encouraging and have led to an ongoing international study being conducted in 196 hospitals worldw...
If you’re at risk of prostate cancer — in other words, if you’re male — the best place to be is the United States, where survival rates are highest in
LeBron James is a proud celebrator of Movember, the annual November event that encourages men to grow mustaches to raise awareness for prostate cancer. And, boy, has the Cavaliers star taken things to new levels. On Tuesday, he became a villain from a circa-1920s silent movie. Mooostash on deck! #Movember #StriveForGreatness A photo posted by […]
Men with prostate cancer run the risk of brittle bones as a side-effect of their treatment. But one hour's football training a few times a week counters many of the negative effects of the treatment, according to University of Copenhagen scientists. Football training is not just good for the heart and the muscles. Show More Summary
Men receiving radiation therapy for prostate cancer may find twice-weekly yoga sessions can help maintain life quality and alleviate some side effects, new research suggests.
Mal Whifield, the famed Olympian who won three Olympic gold medals between 1948 and 1952 — one while serving as a Tuskegee Airman for the Air Force during the Korean War — has died from heart disease and prostate cancer, according to his daughter, Fredricka Whitfield. Show More Summary
Screening for prostate cancer becomes more reliable, less expensive for U.S. healthcare system.
A University of Alberta researcher's work to identify patients at greatest risk of prostate cancer cells spreading to another part of the body has earned a top award at a showcase of the world's best up-and-coming research talent.
Vituro Health has launched operations to offer complete prostate management services, including minimally-invasive high intensity focused ultrasound (HIFU) therapy. Stephen Scionti, M.D., is the leading U.S. HIFU expert and Vituro Health's first partner physician.
This week on Movember Radio Mo Bro Lou Silluzio opens up about losing it all in the recession, building a new business and battling prostate cancer three times. The post Mo Bro Lou Silluzio Opens up about his Life’s Ups and Downs appeared first on The Good Men Project.
HMM: Early Prostate Cancer Cases Fall Along With Screening. “Fewer men are being screened for prostate cancer, and fewer early-stage cases are being detected, according to two studies published Tuesday in The Journal of the American Medical Association. The number of cases has dropped not because the disease is becoming less common but because there […]
A new study shows that clinicians are far less inclined to order a PSA test for a patient after the 2012 updates to screening guidelines.
Advanced prostate cancer is a disease notoriously resistant to treatment. New research sheds light on a new mode of drug resistance to emerging therapies in metastatic prostate cancer. This discovery ultimately may help predict which patients may benefit most from treatment.
A study that tracked tens of thousands of midlife and older men for more than 20 years has found that vigorous exercise and other healthy lifestyle habits may cut their chances of developing a lethal type of prostate cancer by up to 68 percent.
Christopher J. Kane, M.D., a renowned specialist in prostate cancer and an expert in robotic and other minimally invasive procedures for urologic surgery at the University of California, San Diego, has been appointed the inaugural holder of the Joseph D. Schmidt, MD Presidential Chair in Urology in the School of Medicine.
A secreted protein predominantly expressed in bone inhibits prostate cancer metastasis to bone, new research shows. Prostate cancer is the most frequently diagnosed cancer and the second leading cause of cancer-related deaths among men in the United States. Show More Summary
But whether that's good or bad isn't yet clear
SEATTLE -- Advanced prostate cancer is a disease notoriously resistant to treatment. New research by scientists at Fred Hutchinson Cancer Research Center and the University of California, San Francisco sheds light on a new mode of drug resistance to emerging therapies in metastatic prostate cancer. Show More Summary